China Digest: Sumgen raises $32m; inCarey bags $30m from Long Hill Capital

Hangzhou Sumgen Biotech has secured 220 million yuan ($32 million) in a Series B round of financing led by Addor Capital, while digital healthcare platform inCarey has raised $30 million Series B+ exclusively from Long Hill Capital.